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ways (using tyramine,  L -NAME, a cyclo-oxygenase (COX-1) in-
hibitor indomethacin, and ATP release).  Conclusions: The 
live kidney slice model is a valid complementary technique 
for investigating vasa recta function in situ and the role of 
pericytes as regulators of vasa recta diameter. This tech-
nique may also be useful in exploring the role of tubulovas-
cular crosstalk in regulation of medullary blood flow. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Regulation of renal medullary blood flow in physio-
logical and pathophysiological situations is still poorly 
understood because of the relative inaccessibility of the 
medullary microcirculation in vivo. In vitro studies using 
isolated descending vasa recta (DVR) have proposed that 
several local and systemic factors, such as endothelins 
(ET), eicosanoids, nitric oxide (NO), angiotensin-II (Ang-
II), adenosine, and ATP, may be involved in its regulation 
 [1] . Regional perfusion studies in which laser Doppler op-
tical fibres have been placed in the renal parenchyma to 
measure autoregulation of medullary blood flow suggest 
a link between changes in blood flow, extracellular fluid 
volume regulation, and salt and water excretion  [2–5] . It 
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 Abstract 
 Background: Medullary blood flow is via vasa recta capillar-
ies, which possess contractile pericytes. In vitro studies using 
isolated descending vasa recta show that pericytes can con-
strict/dilate descending vasa recta when vasoactive sub-
stances are present. We describe a live kidney slice model in 
which pericyte-mediated vasa recta constriction/dilation 
can be visualized in situ.  Methods: Confocal microscopy was 
used to image calcein, propidium iodide and Hoechst label-
ling in ‘live’ kidney slices, to determine tubular and vascular 
cell viability and morphology. DIC video-imaging of live kid-
ney slices was employed to investigate pericyte-mediated 
real-time changes in vasa recta diameter.  Results: Pericytes 
were identified on vasa recta and their morphology and 
density were characterized in the medulla. Pericyte-mediat-
ed changes in vasa recta diameter (10–30%) were evoked in 
response to bath application of vasoactive agents (norepi-
nephrine, endothelin-1, angiotensin-II and prostaglandin E 2 ) 
or by manipulating endogenous vasoactive signalling path-
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is also thought that the medullary circulation (vasa recta 
capillaries) is autoregulated (in DVR capillaries over the 
range of 85–160 mm Hg) and that changes in medullary 
blood flow are not simply a passive response to changes 
in renal artery blood flow or pressure; although exactly 
how this is achieved is still unclear  [6] . Furthermore, this 
subject is not without controversy, the concept of medul-
lary autoregulation has yet to be widely accepted by the 
field.
 Until recently, regulation of tissue blood flow was 
thought to occur at the level of the arteries and pre-cap-
illary arterioles; however, it has been shown that special-
ized contractile smooth muscle-like pericyte cells found 
on capillaries can control capillary diameter in situ in 
whole retina and in cerebellar brain slices  [7] . This is also 
relevant to the renal medulla, because pericyte cells are 
present along DVR capillaries  [8] . In vitro studies using 
isolated DVR suggest that the medullary microcircula-
tion is likely to be regulated by locally released vasoactive 
agents independent of any changes in cortical blood flow 
 [9–14] . Moreover, changes in medullary blood flow are 
thought to play an important part in the pathogenesis of 
acute kidney injury  [15] , and medullary tubulovascular 
crosstalk could be critical to the control of medullary 
blood flow in health and disease.
 Since the medulla is not readily accessible to direct ob-
servation in vivo, except in neonatal rats where the pa-
pilla can be exposed by opening the renal pelvis  [16] , there 
have been no studies of DVR regulation in the intact me-
dulla, although it is known that pericytes respond to ex-
ogenous application of vasoactive agents that can alter 
isolated DVR diameter  [17] . The inaccessibility of the in-
tact medulla means that key endogenous regulators of 
DVR blood flow have not been investigated in the intact 
kidney in situ or in vivo. To address this issue, we have 
developed a ‘live’ intact kidney slice model to investigate 
pericyte-mediated regulation of vasa recta diameter in 
situ in the renal medulla. A potential advantage of the 
kidney slice model is that although vasa recta are not per-
fused, the surrounding tubules and local innervation re-
main intact, and their contributing effects on vasa recta 
diameter can be explored.
 Materials and Methods 
 Tissue Slicing 
 Animal experiments were conducted in accordance with 
United Kingdom Home Office Scientific Procedures Act (1986). 
Adult male Sprague-Dawley rats (250–300 g, purchased from 
Charles River UK Ltd, Kent, UK) were killed by cervical disloca-
tion; their kidneys were immediately removed and placed in ice-
cold physiological saline solution (PSS) bubbled with 95% O 2 /5% 
CO 2 and prepared for slicing. Prior to slicing, the kidneys were 
de-capsulated and any renal artery remnants removed. A single 
kidney was secured on the slicing block of a vibratome tissue slic-
er (Leica model VT1200S; Leica Microsystems (UK) Ltd, Milton 
Keynes, Bucks., UK), and submerged in a bath of ice-cold PSS 
bubbled with 95% O 2 /5% CO 2 . PSS contained (m M ) 100 NaCl,
5 KCl, 0.24 NaH 2 PO 4 , 0.96 Na 2 HPO 4 , 10 Na acetate, 1 CaCl 2 , 1.2 
MgSO 4 , 5 glucose, 25 NaHCO 3 , 5 Na pyruvate (Sigma-Aldrich 
Ltd, Poole, Dorset, UK). The pH was adjusted to 7.4 using 10  M 
NaOH. The outer cortical dome region (  3 mm tissue) of the kid-
ney was removed to expose the top of the renal medulla and se-
rial 200   m-thick coronal kidney slices (in which there was intact 
cortex and medulla) were cut. Slices were collected and main-
tained at room temperature in a holding chamber containing PSS, 
and bubbled with 95% O 2 /5% CO 2 to conserve tissue viability. The 
slices to be used in ‘live’ experiments were maintained for up to 3 
h in the holding chamber, or slices were fixed with 4% parafor-
maldehyde (Sigma-Aldrich Ltd) and used for immunohistochem-
istry.
 Tissue Viability 
 To confirm the viability of kidney slices, an on-stage perfusion 
system was used to load fluorescent dyes into the slices to label all 
cells (Hoechst 33342) and dead cells (propidium iodide (PI)). 
Non-fixed kidney slices were secured with a slice anchor in an 
open-bath chamber (  1.5 ml volume) (Harvard Apparatus, 
Edenbridge, Kent, UK) and superfused with PSS bubbled with 
95% O 2 /5% CO 2 at 5 ml/min. Slices were imaged using a Zeiss 510 
NLO Axiovert microscope coupled to a tuneable Coherent Cha-
meleon laser. Prior to imaging of kidney slices, we established the 
optimum excitation wavelength for each relevant probe imaged 
using the 2-photon laser, by generating a 2-photon excitation 
spectrum. Hoechst 33342 (Invitrogen Ltd, Paisley, UK) was used 
at 5   M to label all cell nuclei and was excited at 720 nm. PI (Sig-
ma-Aldrich Ltd) is taken up by cells with compromised cell mem-
branes and was used at 20   M to label the nuclei of all dead cells 
and was excited at 543 nm with a single photon laser. Emitted light 
was collected with the following filters: band-pass 435–485 nm 
(Hoechst 33342) or long-pass 560 nm (PI). Image processing was 
performed using Zeiss LSM image browser software (Carl Zeiss 
Ltd, Welwyn Garden City, Herts., UK). The ratio of live:dead cells 
(Hoechst labelled:Hoechst-PI co-labelled, respectively) was also 
calculated using Zeiss LSM image browser software.
 To further validate cell viability, and to distinguish between 
tubular and vascular cells, live kidney slices were incubated for 20 
min with the cell-permeant calcein-AM dye. This non-fluores-
cent dye is converted to a bright green fluorescence by intracel-
lular esterases following uptake into live cells  [18] . Calcein-AM 
(Invitrogen Ltd) was used at 2   M (in 0.002% pluronic acid) as a 
vital stain and excited at 800 nm; emitted light was collected using 
band-pass 500–550 nm. Image processing was performed using 
Zeiss LSM image browser software, as before.
 Immunohistochemistry 
 Live kidney slices were incubated with Alexa Fluor 488-conju-
gated isolectin B 4 (IB 4 ) (Invitrogen Ltd) – a marker for   - D -galac-
tosyl residues – to identify the vasa recta capillaries. IB 4 (50   g/ml) 
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cubated with IB 4 for 45 min, washed with PSS and subsequently 
fixed using 4% paraformaldehyde. Fixed kidney slices were then 
incubated for 16 h with the anti-neural-glial 2 (NG2) polyclonal 
antibody (Millipore UK Ltd, Watford, UK). The anti-NG2 anti-
body, previously used to identify pericytes in the CNS  [7] , was 
probed with an Alexa Fluor 555-conjugated donkey anti-rabbit sec-
ondary antibody (Invitrogen Ltd). For experiments in which peri-
cytes were co-localized with sympathetic nerves, slices were incu-
bated with anti-NG2 and anti-tyrosine hydroxylase (Vector Labo-
ratories Ltd, Peterborough, UK) primary antibodies, respectively. 
The tyrosine-hydroxylase signal was amplified with a biotinylated 
secondary antibody and probed with a FITC-conjugated tertiary 
antibody (Fluorescent Avidin Kit; Vector Laboratories Ltd). Kidney 
slices were mounted using Citiflour (Agar Scientific Ltd, Stanstead, 
Essex, UK) and the medulla of fixed slices were imaged using a 
Zeiss LSM 510 laser scanning confocal microscope (Carl Zeiss Ltd). 
Alexa 488-conjugated IB 4 and FITC-conjugated secondary anti-
bodies were excited at 488 nm and Alexa Fluor 555-conjugated sec-
ondary antibody excited at 543 nm. Emitted light was collected 
with the following filters: long-pass 560 nm (Alexa Fluor 555) and 
band-pass 505–550 nm (FITC and IB 4 ). Pericytes on the vasa recta 
were imaged in both the inner and outer medulla.
 Confocal images of fluorescently labelled pericytes (Alexa 555, 
red) and vasa recta capillaries (Alexa 488, green) were used to:
(i) calculate the density of pericytes in both the inner and outer 
medulla, (ii) to measure the average primary 1° process length  [19] 
and cell body length of pericytes in both regions. For density cal-
culations,  6 3  ! 100-  m 2 regions in both the inner and outer 
medulla of every kidney slice were selected at random (n = 20 for 
inner and outer medulla). Measurements of pericyte cell body 
length and 1° process lengths in both the outer and inner medul-
la were measured using Zeiss LSM image browser software.
 Functional Experiments and Analysis 
 Live kidney slices were secured in an open-bath chamber us-
ing a purpose-built platinum slice anchor and transferred to the 
stage of an upright Olympus microscope (model BX51WI; Olym-
pus Microscopy, Southend-on-Sea, Essex, UK). Kidney slices 
were continuously superfused (  2.5 ml/min, 1.25 ml bath vol-
ume) with PSS, bubbled with 95% O 2 /5% CO 2 and maintained at 
room temperature. Pericytes on the vasa recta capillaries (vasa 
recta were defined as  ! 10   m in diameter) were identified by their 
previously established ‘bump-on-a-log’ morphology  [7] , and DIC 
images were captured through an Olympus 60 ! water immer-
sion objective (0.9 NA). Real-time video images of changes in vasa 
recta diameter were collected every second by an attached Rolera 
XR CCD camera and recorded using Image Pro Software (Me-
dia Cybernetics Inc., Marlow, Bucks., UK). Live kidney slices
were superfused with the following vasoactive compounds:
Ang-II (10 and 100 n M ; see online supplementary video 1, www.
karger.com/doi/10.1159/000339110), norepinephrine (NE; 10 n M ), 
endothelin-1 (ET-1; 10 n M ), indomethacin (30   M ), and  L -N G -ni-
troarginine methyl ester ( L -NAME; 1 m M ), to evoke vasoconstric-
tion, and the NO donor, S-nitroso-N-acetyl- D,L -penicillamine 
(SNAP; 100   M ) and prostaglandin E 2 (PGE 2 ; 10   M ) were used 
to evoke vasodilation. All vasoactive compounds were purchased 
from Sigma-Aldrich Ltd), and working solutions were prepared in 
oxygenated PSS. In experiments in which ATP release (from tu-
bules) was stimulated, a hypotonic PSS solution (NaCl concentra-
tion reduced by 5%) was applied to live kidney slices.
 Time-series analysis of live kidney slice experiments was car-
ried out using the public domain software ImageJ (NIH, http://
rsb.info.nih.gov.ij). For each experiment, both a pericyte site and 
a non-pericyte site were identified on a single vasa recta. The di-
ameter of the vasa recta at both locations was measured every 5 
frames for the duration of the experiment (1 frame = 1 s). Typi-
cally, kidney slices were superfused with PSS alone for 70 s to es-
tablish a baseline vessel diameter at the pericyte and non-pericyte 
site. Slices were then exposed to an agonist/antagonist to evoke a 
change in vasa recta diameter, and were then subjected to a PSS 
wash (see online suppl. video 1). Each capillary acted as its own 
control; an average of the first 5 measurements was taken to rep-
resent the resting baseline diameter value (D b ), and expressed as 
100%, for both pericyte and non-pericyte sites. All subsequent 
diameter measurements (D) were calculated and expressed as a 
percentage of the corresponding baseline value for both pericyte 
and non-pericyte sites (see equations 1 and 2). Percentage change 
in vessel diameter was calculated from actual vessel diameter 
measurements made throughout each experiment; the smaller 
changes in a vessel diameter reported here (e.g. 2% of 9.5   m ves-
sel) are calculated rather than measured changes. In our experi-







% Δ vessel diameter 100
mean baseline diameter D
 ¬­ ­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  (1)
 % constriction or dilation = 
100% (baseline) – %   vessel diameter                                                                                             (2)
 For all experiments, statistical significance was calculated us-
ing Student’s t test; p  ! 0.05 was considered significant. Values are 
expressed as mean  8 SE. N numbers displayed represent number 
of pericytes (1 pericyte and non-pericyte site per kidney slice), 
since the variation observed, and found in similar kidney  [20] and 
CNS studies  [7] , occurred between pericytes and not animals. All 
experiments were performed in at least 3 different animals. One 
vasa recta per kidney slice was used to ensure all vessels were ‘na-
ive’ prior to exposure to any drug.
 Results 
 Viability of Kidney Tissue Slices 
 A selection of fluophores was used to assess the viabil-
ity of the live kidney tissue slices.  Figure 1 a shows a typi-
cal live kidney slice loaded with Hoechst ( fig. 1 ai) and PI 
( fig. 1 aii), an overlay of Hoechst and PI ( fig. 1 aiii), a bright-
field DIC image of the corresponding area ( fig. 1 aiv), and 
an overlay of all images ( fig. 1 av). In three independent 
experiments we determined the ratio of Hoechst:Hoechst 
and PI (live:dead) labelled nuclei to be 5: 1 (per 100   m 2 , 
n = 5 slices, n = 3 animals), indicating that the majority 
of tubular and vascular cells within the kidney slice were 
live, thus confirming the tissue slices were viable 
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the viable marker calcein and were clearly fluorescent, 
and therefore considered viable (n = 9 slices, n = 3 ani-
mals;  fig. 1 b). In addition, it was observed that capillaries 
and vessels consistently run in parallel in the renal me-
dulla. Tubules of different sizes were observed, ranging 
from 10 to 40   m in diameter (n = 9 slices, n = 3 animals). 
The average diameter of vasa recta capillaries was 7.9  8 
0.6   m (n = 9 slices, n = 3 animals). Pericytes were iden-
tified on the outside of capillaries by their previously de-
fined ‘bump-on-a-log’ morphology  [7] and they were also 
fluorescent, indicating that pericytes in our live kidney 
slices were also viable ( fig. 1 c, arrowhead).
 Characteristics of Vasa Recta Pericytes in situ 
 Vasa recta and pericytes were labelled with fluores-
cently conjugated IB 4 ( fig.  2 ai) and with anti-NG2 
( fig. 2 aii), respectively. Confocal images of labelled kid-
ney slices were used to identify the prominent pericytes 
cell body (bump-on-a-log) and processes that run along 
and wrap around the abluminal surface of vasa recta cap-
illaries ( fig. 2 aiii). Pericytes were observed at regular in-
tervals along the vasa recta in both the inner and outer 
medulla. 1° processes were seen to extend from the peri-
cyte cell body along and around the vasa recta ( fig. 2 aiii), 













 Fig. 1. Viability of kidney slices. Confocal images of kidney slices 
incubated with Hoechst and PI to label nuclei of all ( ai ) and dead 
( aii ) cells, respectively. Overlay of images  ai and  aii demonstrates 
the ratio of live:dead cells ( aiii ). The corresponding brightfield im-
age indicates the location of pericytes ( aiv , black dotted lines) on 
a single vasa recta capillary ( aiv , white dotted lines). Overlay of 
images  ai–aiv shows all pericytes in this field of view are live ( av ). 
Calcein uptake is shown in tubules (t) and vasa recta capillaries 
(vr) in the renal medulla of live kidney slices ( b ). Pericytes (ar-
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 [19] . IB 4 labelling did not distinguish between descend-
ing (DVR) and ascending (AVR) limbs.
 Wide-field images of vasa recta and pericytes were 
collected from 3 animals, 3 tissue slices per animal, and 
pericyte characteristics were determined by analysing 
100   m 2 areas in both inner and outer medulla regions 
per kidney slice ( fig 2 b). The pericyte density per 100 
  m 2 in the outer medulla was significantly greater than 
that in the inner medulla (n = 20, 100   m 2 regions ana-
lysed for each region, p  ! 0.05;  table 1 ). There was no sig-
nificant difference in pericyte cell body or process length 
between the inner and outer medulla; the mean pericyte 
cell body length was 9   m (n = 99) and mean pericyte 
process length was 9   m (n = 158;  table 1 ). The mean 
distance between pericyte cell bodies was 16   m (n = 91). 
Interestingly, process length ranged from 2 to 18   m, 
with 1° processes running along the vasa recta and wrap-
ping around the vessel ( fig. 2 ci, ii).
 Sympathetic nerve varicosities in the medulla were
labelled with an anti-tyrosine hydroxylase antibody and 
were found to run along vasa recta in close proximity to 
both inner and outer medullary pericytes ( fig. 3 ). Stain-
ing for sympathetic nerves was predominantly detected 
in the outer medulla, in keeping with the higher density 



















 Fig. 2. Identification and characterization of pericytes on vasa 
recta capillaries in the renal medulla. Vasa recta capillaries (vr) 
were labelled with Alexa-488-conjugated IB 4 ( ai , green). The cell 
body (arrowheads) and processes (arrows) of pericytes in the renal 
medulla were labelled with anti-NG2 and Alexa-555-conjugated 
secondary antibody ( aii , red). An overlay of images  ai and  aii iden-
tifies pericytes (red) on vasa recta capillaries (green) ( aiii ). The 
density of pericytes was calculated for both inner and outer me-
dulla, by selecting 100-  m 2 regions in confocal images of NG2 
and IB 4 -labelled kidney slices ( b ). A magnified image of a pericyte 
( ci ) shows the cell body and processes (dotted lines indicate outer 
vessel wall). Cell body length and 1° processes (running along and 
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 Effect of Vasoactive Agents on Vasa Recta Diameter in 
situ 
 The initial resting internal diameter of vasa recta cap-
illaries was 7.5  8 0.4   m at pericyte sites, significantly 
narrower than at non-pericyte sites (9.5  8 0.4   m, n 
 1 30, p  ! 0.001). Several vasoactive compounds were test-
ed for their ability to alter vasa recta diameter at pericyte 
and non-pericyte sites. Changes in vessel diameter were 
determined by measuring the diameter of the capillary 
at pericyte and non-pericyte sites before, during, and af-
ter the application of a vasoactive compound (see Meth-
ods, and  figure 4 ai–iii and online suppl. video 1 for ex-
ample of Ang-II-evoked constriction). A representative 
trace showing the Ang-II (100 n M )-evoked change in ves-
sel diameter at a pericyte and corresponding non-peri-
cyte site is displayed in  figure 4 b. We calculated that, on 
average, 51% of pericytes responded to agonist exposure 
by changing vessel diameter. The success rate ranged 
from 35 to 85% depending on the agonist vessels were 
exposed to. Ang-II (100 n M ) caused a significantly great-
er vasoconstriction (  4-fold) at pericyte sites (29.3  8 







Pericyte density (per 100 m2) 9.180.5* 12.481.2 10.880.7
Pericyte cell-body length, m 8.980.2 9.180.2 9.080.2
Distance between pericytes, m 16.081.2 15.181.1 15.681.8
1° process length, m
Along vessel 7.980.5 8.980.6 8.380.4
Around vessel 0.380.6 8.680.5 9.080.4
Combined 8.680.4 8.781.1 8.780.3
P ericyte density, cell-body length, distance between pericytes, 
and 1° process lengths of the inner and outer medulla were calcu-
lated from confocal images of NG2-stained kidney slices (n = 3 
slices per animal, n = 3 animals). Pericyte density was calculated 
from 100-m2 regions in the inner and outer medulla. Values are 







 Fig. 3. Co-localization of pericytes and 
sympathetic nerves in the renal medulla. 
Confocal image of vasa recta pericytes la-
belled with anti-NG2 and Alexa-555-con-
jugated secondary antibody ( a , red). Sym-
pathetic nerve varicosities were identified 
with FITC-labelled anti-tyrosine hydroxy-
lase ( b , green). An overlay of images  a and 
 b shows pericytes (red) co-localized with 
sympathetic nerves (green) on a vasa recta 
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4.7%) than at non-pericyte sites (7.6  8 1.9%, n = 14 slic-
es, n = 6 animals, p  ! 0.001;  fig. 4 c, online suppl. video 
1). Similarly, NE (10 n M ) significantly decreased vasa rec-
ta diameter by 20.8  8 5.1% at pericyte sites compared 
with 7.6  8 2.0% at non-pericyte sites (p  ! 0.05, n = 7 
slices, n = 3 animals;  fig. 5 ai); ET-1 (10 n M ) also caused 
significant vasoconstriction at pericyte sites (10.3  8 
1.9%) compared with non-pericyte sites (2.4  8 1.7%, n = 
6 slices, n = 3 animals, p  ! 0.05;  fig.  5 bi). Using Poi-
seuille’s law, which assumes laminar flow, as an approx-
imation  [21] , and not allowing for the presence of red 
blood cells  [22] , the constriction evoked by NE (21%), 
Ang-II (29%) and ET-1 (10%) would increase resistance 
to blood flow by 2.7-, 4- and 1.5-fold, respectively. The 
application of the NO donor SNAP (100   M ) caused a 
modest but significantly greater dilation of vasa recta at 
pericyte sites (12.6  8 2.9%) compared with non-pericyte 
sites (3.7  8 1.3%, n = 15 slices, n = 8 animals, p  ! 0.01; 
 fig. 5 ci). Representative images of NE, ET-1 and SNAP-
evoked changes in vessel diameter at pericytes are shown 
in  figure 5 aii–iv, bii–iv and cii–iv, respectively.
 In further experiments, the Ang-II (10 n M )-evoked 
and ET-1 (10 n M )-evoked constrictions of vasa recta at 
pericyte sites was attenuated by the NO donor SNAP (100 
  M ;  fig. 6 ). Ang-II (10 n M ) and ET-1 (10 n M ) evoked an 
18.0  8 2.7% (n = 4 slices, n = 3 animals) and 8.5  8 1.9% 
(n = 10 slices, n = 3 animals) constriction at pericyte sites, 
respectively, which was significantly greater than that 
measured at non-pericyte sites (2.8  8 0.7%, p  ! 0.01, n = 
4 slices, n = 3 animals, and 4.7  8 1.4%, p  ! 0.05, n = 10 
slices, n = 3 animals, respectively). SNAP (100   M ) re-
duced the Ang-II (10 n M )-evoked constriction by 67.7% 
(to 5.8  8 1.6%) at pericyte sites ( fig. 6 ), and the ET-1 (10 
n M )-evoked constriction by 145.9% thus causing vasa 
recta to dilate to +3.9  8 1.9% of the original resting di-






















































 Fig. 4. DIC imaging of pericyte-mediated 
constriction of in situ vasa recta capillar-
ies. Images taken from a time series exper-
iment in which kidney slices were exposed 
to Ang-II. A typical field of view of a vasa 
recta capillary superfused with control 
PSS solution is shown ( ai ). Red blood cells 
are seen in the lumen and pericytes located 
on capillary walls ( ai , arrowhead). Red and 
yellow dotted lines highlight the regions 
along the vasa recta where the vessel diam-
eter was measured at pericyte sites and 
non-pericyte sites, respectively ( ai–iii ). 
Application of Ang-II (100 n M ) caused a 
reduction in vasa recta diameter at the 
pericyte site ( aii ). Following removal of 
Ang-II from the perfusate, the vasa recta 
returned to resting diameter ( aiii ). A rep-
resentative trace ( b ) of % change in vasa 
recta diameter at a pericyte site (red trace), 
and non-pericyte site (grey trace), in re-
sponse to Ang-II (100 n M ) exposure. Mean 
data for these experiments shows Ang-II 
(100 n M ) evoked a significantly greater va-
soconstriction at pericyte sites (black bar) 
compared with non-pericyte sites (grey 













































































































 Fig. 5. Effect of vasoactive compounds on vasa recta diameter. 
Superfusion of live kidney slices with NE (10 n M ), and ET-1 (10 
n M ) evoked a significantly greater constriction of vasa recta at 
pericyte sites (black bars) than non-pericyte sites (grey bars),  ai 
and  bi , respectively. The NO donor, SNAP (100   M ) evoked a sig-
nificantly greater dilation of vasa recta at pericyte sites compared 
with non-pericyte sites ( ci ). Values are mean  8 SE,  *  p  ! 0.05. 
Representative images of a pericyte site and non-pericyte site pre-
drug exposure ( i ), during superfusion of the drug ( ii ), and during 
washout of the drug ( iii ), are shown for experiments  a–c . Pericytes 
are denoted by black dotted circles, red dotted lines indicate where 
maximal constriction/dilation occurs at pericyte sites, and yellow 
dotted lines indicate the corresponding non-pericyte region of 
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the perfusate caused a further dilation by SNAP to +3.7 
 8 1.6% of the original resting diameter at pericyte sites 
(p  ! 0.05, n = 4 slices, n = 3 animals;  fig. 6 ), whereas re-
moval of ET-1 from the perfusate, leaving SNAP alone, 
failed to evoke a further significant dilation at either peri-
cyte or non-pericyte sites. SNAP also failed to attenuate 
the Ang-II-evoked constriction of vasa recta at pericyte 
sites when higher concentrations of Ang-II (100 n M ) were 
used (data not shown). No significant changes in vasa rec-
ta diameter were observed at non-pericyte sites during 
these experiments (data not shown).
 Co-application of the AT 1 receptor antagonist losartan 
(10 n M ) with Ang-II (100 n M ) significantly and reversibly 
attenuated the Ang-II (100 n M )-evoked vasoconstriction 
of vasa recta at pericyte sites (15.3  8 1.9%) by   30% to 
10.9  8 2.2% (p  ! 0.05, n = 8 slices, n = 3 animals;  fig. 7 ). 
Higher concentrations of losartan (100 n M ) irreversibly 
abolished the Ang-II-evoked vasoconstriction of vasa 
recta at pericyte sites (n = 9 slices, n = 3 animals;  fig. 7 ). 
Superfusion of live kidney slices with the AT 1 receptor 
antagonist losartan alone, at both 10 and 100 n M had no 
significant effect on vasa recta diameter at pericyte sites 
( fig. 7 ). No significant change in vasa recta diameter was 
observed at non-pericyte sites during these experiments 
(data not shown).
 Attenuating Endogenous NO and PGE 2 Release in 
Kidney Slices 
 Indomethacin and  L -NAME were applied to kidney 
slices to attenuate the endogenous release of prostaglan-
dins and NO, respectively. Application of the non-se-
lective cyclooxygenase inhibitor indomethacin (30   M ) 
evoked a significantly greater constriction of vasa recta at 
pericyte sites (9.9  8 0.5%) than at non-pericyte sites (2.1 
 8 0.3%, n = 13 slices, n = 5 animals, p  ! 0.05;  fig. 8 ai) that 
was consistent with attenuation of production of vasodi-
lator prostaglandins such as PGE 2 . This effect was revers-
ible following removal of indomethacin. Application of 
PGE 2 to kidney slices evoked dilation of vasa recta that 
was significantly greater at pericyte sites than at non-
pericyte sites (8.6  8 1.6 and 1.0  8 0.8% respectively, n = 
5 slices, n = 4 animals; p  ! 0.01;  fig. 8 aii).





















Agonist + SNAP (100 μM)
SNAP (100 μM)
 Fig. 6. Co-application of SNAP with agonist (Ang-II or ET-1) at-
tenuated the agonist-evoked constriction of vasa recta at pericyte 
sites. Co-application of SNAP (100 n M ) with either Ang-II (10 n M ) 
or ET-1 (10 n M ) significantly decreased both the Ang-II- and ET-
1-evoked constriction at pericyte sites, by 70% (n = 4) and 150% 
(n = 10), respectively. Removal of Ang-II (10 n M ) from the perfus-
ate caused a further dilation of vasa recta at pericyte sites beyond 
resting diameter, removal of ET-1 (10 n M ) did not result in any 
greater dilation. No significant change in the vessel diameter was 
measured at non-pericyte sites throughout the experiment. Val-






















 Fig. 7. The AT 1 receptor antagonist, losartan, concentration-de-
pendently blocked the Ang-II (100 n M )-evoked constriction of 
vasa recta at pericyte sites. Losartan alone (10 n M or 100 n M ) had 
no effect on capillary diameter (n = 8 and n = 9, respectively). 
Losartan (10 n M , black bars) significantly and reversibly attenu-
ated (  30%) the maximum Ang-II (100 n M )-evoked vasocon-
striction of vasa recta by pericytes (n = 8). Losartan (100 n M ,
grey bars) significantly and irreversibly blocked vasoconstriction 
of vasa recta by Ang-II (100 n M , n = 9). Values are mean  8 SE.
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 Application of 1 m M  L -NAME (to inhibit nitric oxide 
synthase and NO production) evoked a significantly 
greater constriction of vasa recta at pericyte sites than at 
non-pericyte sites (8.6 8 .1.1 vs. 1.9  8 0.3%, p  ! 0.05, n = 
7 slices, n = 4 animals;  fig. 8 b) that reversed after remov-
al of  L -NAME. In some experiments following the re-
moval of  L -NAME, we observed a dilation of vasa recta at 
pericyte sites (8.0  8 1.0%), which was significantly great-
er than at non-pericyte sites (1.9  8 0.5%, n = 5 slices, n = 
3 animals, p  ! 0.05;  fig. 8 b). This may be due to a surge in 
NO production following removal of  L -NAME.
 Stimulating Endogenous Release of NA and ATP – 
Demonstrating Neurovascular and Tubulovascular 
Crosstalk 
 Superfusion of live kidney slices with 1   M tyramine 
(to stimulate NE and ATP production and release from 
sympathetic nerve terminals) caused a significantly 
greater vasoconstriction of vasa recta at pericyte sites 
(11.9  8 2.5%) compared with non-pericyte sites (3.0  8 
0.6%, n = 7 slices, n = 4 animals; p  ! 0.05;  fig. 9 a). This 
vasoconstriction was however more moderate than that 


























































 Fig. 8. Attenuating endogenous release of 
NO and PGE 2 in kidney slices. Superfu-
sion of live kidney slices with the COX in-
hibitor indomethacin (30   M ) evoked a 
significantly greater constriction of vasa 
recta at pericyte sites ( ai , black bars) com-
pared with non-pericyte sites ( ai , grey 
bars, n = 13). Superfusion of PGE 2 (10   M ) 
evoked a significantly greater dilation of 
vasa recta at pericyte sites ( aii , black bars) 
compared with non-pericyte sites ( aii , grey 
bars, n = 5). Superfusion of the NOS in-
hibitor  L -NAME (1 m M ) caused a signifi-
cantly greater constriction at pericyte sites 
( b , black bars) than at non-pericyte sites 
( b , grey bars, n = 7). Washout of  L -NAME 
with PSS caused a significantly greater di-
lation of vasa recta at pericyte sites ( b , 
black bars) than at non-pericyte sites ( b , 
grey bars, n = 5). Values are mean  8 SE. 






































 Fig. 9. Stimulating the release of endoge-
nous vasoactive mediators. Superfusion of 
kidney slices with tyramine (1   M ) evoked 
a significantly greater constriction at peri-
cyte sites ( a , black bars) compared with 
non-pericyte sites ( a , grey bars, n = 7). Re-
ducing the osmolarity of the PSS by 5% 
caused a significantly greater dilation at 
pericyte sites ( b , black bars) compared 
with non-pericyte sites ( b , grey bars, n = 5). 
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 Tubular epithelial cells and vascular endothelial cells 
are both known to release vasoactive ATP under condi-
tions of ‘stress’, such as hypotonicity. Reducing the osmo-
larity of the PSS by 5% in the current study caused a sig-
nificant increase in vasa recta diameter at pericyte sites 
(11.4  8 1.7) compared with non-pericyte sites (2.2  8 0.9, 
n = 5 slices, n = 4 animals; p  ! 0.05;  fig. 9 b).
 Discussion 
 The purpose of this study was to develop and explore 
the potential for a  live kidney slice model to investigate 
vasa recta properties and regulation in situ. Although the 
vasa recta are not perfused in this preparation, it has the 
advantage of being intact tissue with both vasa recta and 
adjacent tubules, and preserved intrarenal innervation; 
as such is potentially useful for examining the role of vasa 
recta pericytes in the control of vasa recta capillary diam-
eter, and the effect of exogenously applied and endoge-
nously released vasoactive compounds. Moreover, in the 
absence of an in vivo method to study vasa recta function 
in situ, we have shown that the kidney slice model con-
firms many of the observations already made in isolated 
vasa recta in vitro, and that the slice model may comple-
ment and extend current in vitro techniques.
 Tissue Viability 
 Kidney slices are viable and have an 80% ratio of live 
to dead cells using Hoechst and PI. This is similar to the 
ratio reported previously for healthy rat kidneys  [23] , and 
a value that was also obtained in the established rat brain 
slice preparation  [7] . Furthermore, the uptake of calcein 
into both vascular and tubular cells in the renal medulla 
is not dissimilar to that in the renal cortex of transverse 
cut rat kidney slices shown by Hall et al.  [24] . These find-
ings indicate that kidney slice tissue is viable for physio-
logical experiments.
 Characteristics of in situ Vasa Recta and Their 
Pericytes 
 Using anti-NG2 antibody to identify pericytes  [25] in 
the renal medulla and to investigate the characteristics of 
in situ pericytes on vasa recta capillaries (identified with 
IB 4 ) in live kidney slices, we found a significantly higher 
density of pericytes in the outer medulla compared with 
the inner medulla – similar to previous reports in sec-
tions of tissue dissected from the inner and outer medul-
la of rat kidneys  [26] . We also found a wide range of 1° 
process lengths (2–18   m) extending from the cell body 
and running in parallel along, and wrapping around, the 
vasa recta. Given that the average distance between peri-
cyte cell bodies is   16   m, and the average process length 
is   8   m, there are unlikely to be many regions along the 
vasa recta that are not covered with pericyte processes, 
which probably account for the small changes in vasa rec-
ta diameter ( ! 7%) at non-pericyte sites when Ang-II and 
NE were applied ( fig. 4 c and  5 ai, respectively); endothe-
lial cells are unlikely to contract and cause changes in 
vessel diameter.
 Interestingly, the density of pericytes on vasa recta is 
greater than that reported for many other tissues (for ex-
ample in the mouse, CNS pericytes reside mainly at cap-
illary branch points and have a distance of   50   m be-
tween cell bodies  [27] ). The fluorescently conjugated IB 4 
used to label vasa recta was not able to distinguish be-
tween AVR and DVR in our kidney slices, and we cannot 
comment on AVR/DVR vessel diameter or pericyte den-
sity on DVR versus AVR.
 In this study, sympathetic nerves were identified in 
close proximity to outer medullary pericytes. Since sym-
pathetic nerves release NE, it is likely that these are an 
endogenous source of vasoactive NE in the medulla. 
When applied exogenously to kidney slices, 10 n M NE 
elicited vasoconstriction of vasa recta specifically at peri-
cyte sites (see Results and  fig. 5 ai–iv). The application of 
tyramine also evoked pericyte-mediated vasoconstric-
tion of in situ vasa recta. Given the close proximity of 
sympathetic nerves to vasa recta pericytes, we propose 
that tyramine stimulates local release of NE and ATP 
from sympathetic varicosities, and that this acts at appo-
site pericytes to cause pericyte contraction and constric-
tion of vasa recta at that site. The constriction observed 
in tyramine experiments was however more moderate 
when compared with the pericyte-mediated constriction 
of vasa recta evoked by bath application of 10  n M NE. 
This is not perhaps surprising given that local concentra-
tion of NE has previously been determined for both the 
iris and vas deferens and is in the picomolar range, and 
thus significantly  ! 10 n M  [28] .
 Vasa recta capillaries in our study measured 7–10   m 
in diameter, which is smaller than others have reported. 
Holliger et al.  [29] reported a vessel diameter for both 
AVR (20   m) and DVR (15   m), when investigating vasa 
recta in the exposed papilla of young rats, and more re-
cently vasa recta used in an in vitro microperfusion study 
were reported to have diameters of 13–15   m  [9, 30] . The 
mean resting vessel diameter of non-perfused isolated 
DVR (pericyte vs. non-pericyte sites not defined in this 
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increases to 15.5   m when DVR are perfused with a per-
fusion pressure up to 75 mm Hg. When perfused at a more 
physiological value of 25 mm Hg, mean isolated perfused 
DVR diameter is   14.5   m  [30] , which is much closer to 
the values we determined for the outer vessel diameter 
(12.6  8 0.5   m) in our preparation. However, the mea-
sured diameters of microvessels in the present study are 
for the inner diameter and not the outer (which is usually 
the value given for isolated perfused DVR). The mean di-
ameter of vasa recta at pericyte and non-pericyte sites was 
calculated to be   7.5 and   9.5   m, respectively. Given 
that endothelial cells are generally considered to be 1–2 
  m thick, this could increase vessel diameter to 9.5–11.5 
and 11.5–13.5   m at pericyte and non-pericyte sites, re-
spectively.
 Functional Experiments on Pericytes 
 Agonist-evoked constriction of individual vasa recta 
in situ by pericytes can be measured in real time (see 
online suppl. video 1 as an example). Moreover, we 
found that endogenous signalling mechanisms are func-
tioning in this kidney slice model, and that endogenous 
agents (NO and PGE 2 , NE and ATP) are acting via con-
tractile pericytes to regulate vasa recta diameter, and 
changes in vessel diameter were significantly greater at 
pericyte sites compared with non-pericyte sites in all 
our experiments. Agonist-evoked changes in vasa recta 
diameter were observed at a small proportion of peri-
cyte sites in each vessel, and in total occurred in ap-
proximately 51% of all vessels examined. The lack of re-
sponse of some pericytes here is similar to findings on 
isolated and in situ retinal vessels. A P2X7 agonist con-
tracted 37% of isolated retinal pericytes and capillary 
constriction occurred in only 12% of the total  [31] ; a 
muscarininc agonist contracted just 10% of retinal peri-
cytes  [32] . In whole mount retina, UTP and ATP con-
stricted 30 and 25% of total pericytes, respectively  [7] . In 
cerebellar slices, NA constricted 50% of pericytes, and 
only 20% of pericytes responded to glutamate  [7] . The 
ranging success rate (35–83%) we observed in kidney 
tissue is in line with, or greater than, that observed in 
CNS experiments  [7, 31, 32] (which is presumably in part 
due to the relative potency of the respective agonists 
used and whether they are acting at direct receptors, or 
stimulating endogenous release of other vasoactive 
compounds), and this finding correlates well with our 
observation that pericyte density is greater along vasa 
recta capillaries than along CNS capillaries. We suggest 
that if all pericytes were to constrict uniformly as a syn-
cytium, the resulting vasoconstriction and reduction in 
medullary blood flow would be quite profound and det-
rimental to the already borderline hypoxic tissue. We 
believe that pericytes act to regulate vasa recta diameter 
in a finite way, offering regional redistribution of blood 
flow and fine-tuning of blood flow, as opposed to caus-
ing complete cessation of blood flow. The fact that not 
all pericytes appear to constrict, both in our preparation 
and in other tissue beds investigated to date, does seem 
to support this concept.
 Agonist-evoked changes in vessel diameter were re-
versible and vessels returned to   97% of their original 
resting diameter following removal of all agonists, except 
for ET-1, where vasa recta diameter only returned to 76.5 
 8 5.9%. Our findings agree with previous reports that 
Ang-II, NE and ET-1 significantly reduce blood flow in 
the medulla  [1] . In our experiments we considered an 
agent more likely to reduce medullary blood flow when 
vasa recta diameter (normally   10   m) is decreased 
enough to impede the passage of red blood cells (RBCs; 
diameter of 7–8   m), for example Ang-II (100 n M ) caused 
a 29% decrease in vasa recta diameter, which could sig-
nificantly impede the flow of RBCs.
 Ang-II-evoked vasoconstriction was unusual in that 
vessels started to dilate (toward their resting diameter) 
before the removal of Ang-II. This indicates possible de-
sensitization of AT 1 receptors, perhaps due to release of 
vasodilatory NO. AT 1 receptor-stimulated release of NO 
has been reported in mouse afferent arterioles  [33] ; this 
effect has also been observed in isolated rat DVR in which 
chronic infusion of Ang-II enhanced basal production of 
NO  [34] . Since Ang-II is endogenous to the kidney, it is 
likely that local vasodilatory mechanisms exist to coun-
teract excessive Ang-II-induced vasoconstriction. In-
deed, we have shown that (unperfused) vasa recta in kid-
ney slices are capable of producing NO. Application of 
 L -NAME, an inhibitor of NOS and NO production, 
caused vessels to constrict, suggesting that NO is released 
tonically in kidney slices and that it may determine rest-
ing vessel diameter. In experiments where kidney slices 
were exposed to Ang-II and the NO donor SNAP, SNAP 
attenuated the Ang-II-evoked constriction of vasa recta 
at pericyte sites when the Ang-II concentration was low 
(10 n M ), but not at a higher concentration (100 n M ).
 Another possible trigger for local NO release in the 
slice preparation are RBCs present in the lumen of   50% 
of all vasa recta exposed to Ang-II ( fig.  4 ai–iii). Since 
RBCs are known to release ATP in response to deforma-
tion caused by vessel constriction  [35] , and that ATP can 
then lead to release of NO from the vascular endothelium 
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vasa recta containing RBCs could result in ATP-mediat-
ed release of vasodilatory NO. Of the vasa recta contain-
ing RBCs, 87.5% recovered prior to washout of Ang-II 
compared with vasa recta without RBCs, in which only 
50% recovered prior to Ang-II washout. The AT 1 receptor 
antagonist losartan, at 100 n M , fully and irreversibly 
blocked Ang-II-evoked vasoconstriction of vasa recta at 
pericytes, whereas 10 n M losartan only partially blocked 
this effect. Thus, our findings are consistent with data 
collected in similar experiments on isolated DVR  [37] . 
Inhibition of Ang-II-evoked constriction by losartan 
confirms AT 1 receptors are present on the surface of vasa 
recta pericytes and probably mediate the Ang-II-evoked 
constriction of vasa recta by contracting pericytes.
 In addition to attenuating endogenous production of 
NO, we have also shown that application of indomethacin 
caused vasa recta to constrict (see Results and  fig. 8 ai). 
Indomethacin is a selective COX-1 inhibitor and inhibits 
the synthesis of vasodilatory prostaglandins, including 
PGE 2. We have demonstrated here that PGE 2 evoked va-
sodilation of vasa recta at pericyte sites, this in combina-
tion with the indomethacin-evoked vasoconstriction 
suggests that the pericyte-mediated constriction ob-
served in the presence of indomethacin is in part due to 
inhibition of vasodilatory PGE 2 .
 In order to address the question of whether the live kid-
ney slice model is suitable for investigating tubulovascular 
crosstalk, we sought to initiate ATP release from tubular 
epithelial cells by applying a hypotonic PSS solution to live 
kidney slices. Cultured tubular epithelial cells have previ-
ously been shown to release ATP under conditions of 
stress, such as pressure  [38] , and hypotonicity  [39] . In the 
current study, we observed pericyte-mediated vasodila-
tion in response to application of a hypotonic PSS indica-
tive of ATP-mediated vasodilation. In cerebral vascular 
beds, ATP has been shown to cause both vasoconstriction 
and vasodilation  [40, 41] . Moreover, in the live kidney slice 
model, we have previously demonstrated that high con-
centrations of ATP (100   M ) caused pericyte-mediated 
vasoconstriction  [20] . In experiments where slices were 
exposed to inhibitors of the ATP-gated P2 receptors (sur-
amin), we observed constriction of vasa recta at pericyte 
sites indicating low concentrations of ATP, such as that 
released locally, were tonically acting to dilate vasa recta 
 [20] . Data presented here show that endogenous ATP re-
lease does indeed act to regulate vasa recta diameter; how-
ever, since we cannot demonstrate that the source of ATP 
release is solely tubular in its origin, findings presented 
here are perhaps the first step towards investigating tubu-
lovascular crosstalk mechanisms in situ.
 Ang-II-Evoked Changes in Renal Blood Flow: in situ 
vs. in vitro vs. in vivo 
 To explore the value of this model as an in situ tech-
nique to investigate how medullary blood flow may be 
controlled locally, we compared changes in flow evoked 
by Ang-II in our in situ slice preparation with previously 
published in vitro isolated DVR experiments  [9] , and in 
vivo studies performed in our laboratory using intrarenal 
laser Doppler flowmetry (LDF) in rats [unpubl. data, see 
 42 for method]. Here we utilize Poiseuille’s law to deter-
mine approximate changes in blood flow in response to 
Ang-II. Values presented are an approximation and de-
termined by extrapolating data from measured changes 
in vessel diameter, therefore values are a simplification of 
the likely in vivo blood flow dynamic. Comparing con-
centration-matched data (10 n M Ang-II), we calculated 
an approximate 55% decrease in vasa recta blood flow in 
our slice experiments, which is less than that calculated 
for corresponding in vitro isolated DVR experiments 
(92%). Interestingly, in in vivo LDF experiments follow-
ing the systemic infusion of Ang-II (3   g/min/kg; which 
equates to 250   l of   20   M Ang-II over 5 min; the max-
imum concentration that can be safely infused [unpubl. 
finding]), we observed only a 20.2  8 5.4% (n = 9) change 
in medullary blood flow [unpubl. data]. This in vivo val-
ue is in keeping with other in vivo experiments reported 
in rats in which a 28% change in medullary blood flow 
was measured by LDF following Ang-II infusion  [43] . Re-
sponses calculated for both the in situ slice model and in 
vitro DVR model are higher than the measured in vivo 
response, which is not surprising given the complex phys-
iological regulation of blood in vivo; however, it is inter-
esting that the value obtained using the slice preparation 
is intermediate between the in vitro and in vivo values, 
perhaps reflecting its relatively intact nature, though still 
lacking perfusion, as well as the normal osmotic and ox-
ygen gradients present in vivo.
 Conclusion 
 Many of the limitations of the kidney slice model have 
already been alluded to. Ideally, an improved model 
would include vasa recta luminal perfusion, as well as 
simulation of the osmotic and oxygen gradients found in 
vivo, which are both technically challenging. However, 
despite these limitations, the current model may still have 
a useful place alongside the techniques currently avail-
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